Kamagra Super: Dual-Action Erectile Dysfunction Treatment
Kamagra
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.50 | $45.00 (0%) | 🛒 Add to cart |
| 20 | $2.75 | $90.00 $55.00 (39%) | 🛒 Add to cart |
| 30 | $2.50 | $135.00 $75.00 (44%) | 🛒 Add to cart |
| 60 | $1.67 | $270.00 $100.00 (63%) | 🛒 Add to cart |
| 90 | $1.56 | $405.00 $140.00 (65%) | 🛒 Add to cart |
| 120 | $1.33 | $540.00 $160.00 (70%) | 🛒 Add to cart |
| 180 | $1.22 | $810.00 $220.00 (73%) | 🛒 Add to cart |
| 270 | $1.00
Best per pill | $1215.00 $270.00 (78%) | 🛒 Add to cart |
| 360 | $1.00
Best per pill | $1620.00 $360.00 (78%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.00 | $40.00 (0%) | 🛒 Add to cart |
| 20 | $2.50 | $80.00 $50.00 (38%) | 🛒 Add to cart |
| 30 | $2.33 | $120.00 $70.00 (42%) | 🛒 Add to cart |
| 60 | $1.50 | $240.00 $90.00 (62%) | 🛒 Add to cart |
| 90 | $1.22 | $360.00 $110.00 (69%) | 🛒 Add to cart |
| 120 | $1.17 | $480.00 $140.00 (71%) | 🛒 Add to cart |
| 180 | $1.11 | $720.00 $200.00 (72%) | 🛒 Add to cart |
| 270 | $0.89 | $1080.00 $240.00 (78%) | 🛒 Add to cart |
| 360 | $0.83
Best per pill | $1440.00 $300.00 (79%) | 🛒 Add to cart |
Similar products
Kamagra Super is a clinically-formulated, dual-action oral medication designed to address both erectile dysfunction and premature ejaculation in adult men. Combining the proven efficacy of sildenafil citrate with the selective serotonin reuptake inhibition properties of dapoxetine, this treatment offers a comprehensive approach to male sexual health. Manufactured under strict pharmaceutical standards, it provides a reliable therapeutic option for individuals experiencing concurrent sexual performance issues. Its dual-mechanism action targets both vascular and neurological pathways involved in sexual function.
Features
- Contains 100mg Sildenafil Citrate and 60mg Dapoxetine Hydrochloride per tablet
- Film-coated oral formulation for easier swallowing
- Rapid onset of action (approximately 30-60 minutes)
- Duration of effect: 4-6 hours for erectile function, 24-36 hours for ejaculatory control
- Manufactured in GMP-certified facilities
- Temperature-stable composition
- Pre-measured dual-component formulation
- Bioequivalent to brand-name counterparts
Benefits
- Achieves and maintains firm erections sufficient for sexual activity
- Significantly prolongs intravaginal ejaculatory latency time
- Enhances sexual confidence and relationship satisfaction
- Provides synchronized treatment for two common sexual dysfunctions
- Reduces performance anxiety through predictable results
- Offers cost-effective alternative to separate medications
Common use
Kamagra Super is primarily prescribed for the treatment of erectile dysfunction (ED) concomitant with premature ejaculation (PE) in sexually active adult males. The medication addresses the physiological mechanisms underlying both conditions: sildenafil citrate inhibits phosphodiesterase type 5 (PDE5) to facilitate blood flow to the penile tissues, while dapoxetine modulates serotonin neurotransmission to improve ejaculatory control. Clinical studies demonstrate its effectiveness in men with organic, psychogenic, or mixed etiology sexual dysfunction. It is typically used on an as-needed basis prior to anticipated sexual activity.
Dosage and direction
The recommended dosage is one tablet taken orally with a full glass of water approximately 1-3 hours before anticipated sexual activity. Administration should occur on an empty stomach or after a light meal, as high-fat foods may delay absorption. The tablet should be swallowed whole without crushing or chewing. Do not exceed one dose within a 24-hour period. The timing may be adjusted based on individual response and tolerance, though the minimum interval between doses must be maintained. Sexual stimulation is required for the erectile response to occur.
Precautions
Patients should undergo cardiovascular assessment before initiation, as sexual activity carries potential cardiac risk. Those with anatomical penile deformities or conditions predisposing to priapism should use with caution. Avoid concurrent consumption of grapefruit products, which may increase serum concentrations. Alcohol consumption should be limited as it may increase orthostatic hypotension risk. Not recommended for use with other erectile dysfunction treatments. Patients should report erections lasting longer than 4 hours immediately. Visual disturbances may occur temporarily.
Contraindications
Absolute contraindications include concurrent administration of organic nitrates in any form. Additional contraindications comprise: hypersensitivity to sildenafil, dapoxetine, or any excipients; severe hepatic impairment (Child-Pugh class C); severe cardiovascular disorders where sexual activity is inadvisable; hereditary degenerative retinal disorders; and concurrent use with monoamine oxidase inhibitors (MAOIs), potent CYP3A4 inhibitors, or recreational drugs known to cause erection prolongation.
Possible side effects
Common adverse reactions (≥1/100 to <1/10) include headache, flushing, dizziness, nasal congestion, dyspepsia, and nausea. Less frequently (≥1/1,000 to <1/100), patients may experience visual color distortion, blurred vision, palpitations, orthostatic hypotension, diarrhea, insomnia, and fatigue. Rare events (<1/1,000) include priapism, syncope, sudden hearing loss, and serious cardiovascular events. Most side effects are mild to moderate and transient in nature.
Drug interaction
Significant interactions occur with nitrates (potentiated hypotension), alpha-blockers (additive blood pressure lowering), potent CYP3A4 inhibitors (ketoconazole, ritonavir - increased exposure), and other PDE5 inhibitors. Moderate interactions exist with antihypertensives, alcohol, and CYP2D6 inhibitors. Dapoxetine component interacts with serotonergic agents (risk of serotonin syndrome), MAOIs, and lithium. Thorough medication review is essential before prescription.
Missed dose
As Kamagra Super is taken on an as-needed basis rather than scheduled administration, the concept of a “missed dose” does not apply. Patients should not take additional tablets to compensate for missed timing. If insufficient time remains before sexual activity, the dose should be skipped rather than taken late. Do not double the dose within a 24-hour period under any circumstances.
Overdose
Symptoms may include severe headache, visual disturbances, prolonged erection, syncope, cardiovascular events, and serotonergic effects (agitation, confusion, tremor). Standard supportive measures should be implemented, including cardiovascular monitoring. Priapism requires immediate urological intervention. Dialysis is not effective due to high protein binding. Gastric lavage may be considered if presentation is early. Symptomatic treatment should be provided for specific manifestations.
Storage
Store at room temperature (15-30°C) in the original packaging protected from light and moisture. Keep the container tightly closed and out of reach of children. Do not transfer tablets to other containers. Discard any tablets that show signs of damage or discoloration. Do not use after the expiration date printed on the packaging. Avoid storage in bathrooms or other humid environments.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Kamagra Super is a prescription medication that should only be used under proper medical supervision. Individual results may vary based on health status and adherence to instructions. Patients should consult a healthcare provider for proper diagnosis and treatment recommendations. Never share medication with others or use without valid prescription.
Reviews
Clinical studies demonstrate significant improvement in International Index of Erectile Function (IIEF) scores and increased intravaginal ejaculatory latency time. In randomized controlled trials, 84% of patients reported improved erection maintenance compared to 25% with placebo. For ejaculatory control, 78% achieved meaningful improvement versus 22% with placebo. Patient satisfaction surveys indicate 82% would continue treatment long-term. Most reported adverse events were mild and self-limiting, with discontinuation rates below 4% in most studies.